A quiet teahouse on a late afternoon. Participants: * Dr. Yun: Seasoned healthcare and deep-tech venture investor, candid and reflective after years of front-line battles. * Dr. Peng: Institutional economist and property rights theorist, sharp with structural frameworks and foundational economic principles. Dr. Yun: Ever since I wrote that piece on The Bullfrog in the Well, a fundamental knot has been tightening in my mind. Every time I look at early-stage ventures in deep vertical sectors, the underlying game between risk capital and these academic heavyweights feels downright absurd. From an investor’s perspective, I would love nothing more than to treat a domain giant as an outsourced service—pay them a consulting fee, cap our expenditure, and keep the boundaries crisp. But from the giant’s perspective, all money is fungible. They see capital as a generic commodity. Their ideal setup is to treat us as a loan: if the venture succeeds, pay back the principal with a modest, fixed interest rate, and shove the investor aside. Dr. Peng: That is a fascinating economic inversion. Both sides are fighting over who is the master and who is the tenant, but they are operating on entirely different psychological incentives. Dr. Yun: Exactly. Who is the true master, and who is the guest? At what stage does that balance of power shift? It brings us straight to the fundamental question of innovative enterprises: To whom does the residual ownership truly belong? Back when we were working on our PhDs, Ronald Coase, Douglass North, and Oliver Williamson were dominating the discourse on property rights and transaction costs. The classic debate was relentless: Does capital hire labour, or does labour hire capital? If the domain giant’s accumulated prestige, academic lineage, and clinical experience count as capital—human capital or intellectual capital—how should that balance sheet actually be settled? Dr. Peng: (Takes a slow sip of tea) Dr. Yun, if we retreat to pure economic theory, the textbook answer is quite straightforward: scarcity dictates residual claimancy. Whoever controls the truly scarce production factor holds the bargaining power and ultimately commands the contract. When cash is scarce, physical capital calls the shots. But when an enterprise enters a deeply specialized domain where an academic giant’s insight and access are indispensable, the giant calls the shots. To a theorist, it isn’t an ethical dilemma; it’s an equilibrium pricing game. Dr. Yun: Scarcity? Dr. Peng, that looks immaculate on a blackboard, but out in the mud of venture investing, that neat formula has trapped countless frontline investors. Sure, domain giants are scarce. In ultra-niche domains, their academic pedigree and terminology form an impenetrable moat. But that scarcity is static, sunk, and backward-looking. They leverage privileges accumulated inside legacy institutions as bargaining chips. They demand an uncapped share of future equity upside, yet adamantly refuse to shoulder an ounce of downward operational risk! Dr. Peng: You’re pointing to the classic asymmetry between control rights and residual risk. As Armen Alchian and Harold Demsetz argued in their theory of team production, residual claimancy must belong to the ultimate monitor precisely because they absorb the residual losses. If a domain heavyweight merely leases out their reputation while offloading all downside risk onto the investor, they may be a legal shareholder on paper, but economically, they are simply extracting an exorbitant monopoly rent. Dr. Yun: And that brings us to the core issue: What actually constitutes “Living Labour”? Most people hold a naive view of living labour, assuming it simply means human bodies showing up, clocking in, and expending physical or mental energy, while capital is just inert stuff—land, factories, or raw cash. But in actual production, true living input is far more than biological manpower. Its highest, most vital form is Entrepreneurship. Dr. Peng: That distinction is crucial. In the classical four-factor model of Say and Marshall, routine labour and entrepreneurship are often categorized separately. But if you trace the Austrian and institutional traditions, there is a profound chasm between what is “dead” and what is “alive”: * Routine labour, even when performed by living beings, follows established protocols. Its output is measurable, contractible, and replaceable; hence, it earns a contractual, capped wage. * Only the Schumpeterian function of creative destruction, and what Frank Knight identified as the exercise of subjective judgment under true, unmeasurable uncertainty, constitutes the highest tier of non-contractible, living effort. Dr. Yun: That hits the nail on the head! That is precisely where the domain giants pull off their great illusion. Cloaked in their prestige and academic titles, they claim to be investing high-value “human capital”. But what are they actually contributing? Past papers, tenure, and old institutional relationships—all of which were already monetized and settled years ago in their previous careers! In economic reality, that is not living labour; it is frozen, static objectified capital. Dr. Peng: In other words, they neither provide the daily sweat equity of routine execution, nor do they exercise the high-stakes, skin-in-the-game judgment required of genuine entrepreneurs. Dr. Yun: Not in the slightest! They don’t fly out to pitch resistant enterprise clients, they don’t sign personal guarantees when payroll is short, and they certainly don’t risk their reputations on a venture’s potential failure. They are essentially renting out an antique piece of furniture called their “expert brand” and collecting passive rent! Yet the moment friction arises, their trump card is always that petulant threat: “I’m walking away”. Because of the exit asymmetry, they hold investors hostage with a single point of failure. So many ambitious ventures end up decomposing into ugly repurchase lawsuits just to claw back principal and meager interest. Think about the tragic irony: venture capital takes on catastrophic equity risk, expends immense emotional and cognitive bandwidth, only to be exited like a distressed bondholder; meanwhile, the bullfrog in the well sits on dead, historical baggage and demands the stars! Dr. Peng: This reveals how the master-guest dynamic warps across an enterprise’s lifecycle. During the zero-to-one phase, the domain giant’s static credentials serve as an indispensable gate pass, placing capital in a vulnerable, guest position. But once the company moves into commercial scaling, engineering rigor, regulatory compliance, and GTM execution, the giant’s artisanal intuition rapidly depreciates—and often turns into an impediment. At that juncture, the true scarce resource is the living, relentless entrepreneurial drive that navigates the trenches, matched with living capital willing to risk death alongside it. Dr. Yun: But the bullfrogs never accept that shift! They insist on clinging to majority control, refusing to scale and refusing dilution, dragging the startup into a walking-dead zombie state. That is why my conviction is now crystal clear: In an innovative enterprise, residual ownership belongs neither to passive cash nor to entitled academic relics. It belongs exclusively to those who tie their personal fate to radical uncertainty, using daily Living Labour to fight market entropy! For domain heavyweights, the proper contract is simple: lock them down with capped advisory fees or non-voting options. Buy the gate pass, but never let them touch the steering wheel. Dr. Peng: The pragmatic catch, of course, is that most domain giants will storm out of the room when presented with that offer. Their egos will not tolerate a capped advisory fee. Dr. Yun: (Smiles serenely, hands open) If the frogs refuse, I simply turn around and walk away without wasting a single breath. True composure comes from refusing to jump into the swamp. True residual claimancy shoul… This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit yulingyun.substack.com
